HR 7384
118th Congress
House
Health
Child health
Drug safety, medical device, and laboratory regulation
Prescription drugs
Creating Hope Reauthorization Act of 2024
Introduced: February 15, 2024
Introduced by:
McCaul, Michael T.
Republican
· Texas
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Feb 16, 2024
Referred to the Subcommittee on Health.
Feb 15, 2024
Referred to the House Committee on Energy and Commerce.
Feb 15, 2024
Introduced in House
Plain-English summary
Creating Hope Reauthorization Act of 2024
This bill extends until FY2029 a Food and Drug Administration program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
2